Austco Healthcare Secures Multi-Year Contract Renewal with Major US Hospital Group

Austco Healthcare Limited (ASX: AHC) announced the renewal of a significant Purchase and Maintenance Agreement through its US subsidiary, Austco Marketing and Services (USA) Ltd, with one of the largest healthcare providers in the United States. The renewed agreement ensures continued supply and support of Austco’s Tacera IP Nurse Call system and Tacera Pulse software platform to approximately 180 hospitals across more than 30 states.

This expanded contract builds upon a long-term partnership disclosed in February 2020, which has generated over AU$49 million in revenue for Austco over the past five years. The Tacera Pulse platform is vital in real-time alarm monitoring, KPI tracking, and performance analysis, contributing to enhanced patient care and operational outcomes. The renewed agreement includes no minimum purchase commitments and maintains commercial flexibility. In response to US-China tariff pressures, Austco has also shifted its manufacturing operations outside China, with the transition expected to be finalized within 2–3 months. This renewal reaffirms Austco’s position as a global leader in nurse call and patient management technologies.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com